MAMU
BMY icon

Marathon Asset Management (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Marathon Asset Management (UK)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-854,077
Closed -$44.4M – 103
2018
Q4 		$44.4M Buy
854,077
+161,029
+23% +$8.65M 0.66% 56
2018
Q3 		$43M Buy
693,048
+44,328
+7% +$2.63M 0.54% 64
2018
Q2 		$35.9M Buy
648,720
+470
+0.1% +$25.4K 0.54% 67
2018
Q1 		$41M Buy
+648,250
New +$41.7M 0.63% 60

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Marathon Asset Management (UK)'s BMY Position: Q1 2019 in Review

Marathon Asset Management (UK) sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 854,077 shares — an estimated $44.4M sold.

Marathon Asset Management (UK) first reported a position in BMY in Q1 2018 and held it in 4 quarters. The position peaked at $44.4M in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Marathon Asset Management (UK) reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 854,077 Bristol-Myers Squibb shares in Q1 2019, an estimated $44.4M.
  • Marathon Asset Management (UK) first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 4 quarters.
  • Marathon Asset Management (UK)'s Bristol-Myers Squibb position peaked at $44.4M in Q4 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Marathon Asset Management (UK)'s 13F filing for Q1 2019, filed 2 May 2019.